million people affected worldwide

Current Treatments

Psychedelic research currently is in Not Applicable

If psychedelics are to become medicines at scale, the economics of the treatments do need to work. By work, I mean they will need to be cost-effective to a point that insurers are willing to provide the funds for them. Private (non-medical or non-insured) use will certainly have a place, but the real impact will be realised when psychedelics become part of mainstream healthcare.

This topic page is linked to our papers but doesn’t yet have a full explanation.

Highlighted Institutes

These are the institutes, from companies to universities, who are working on Economics.

Highlighted People

These are some of the best-known people, from researchers to entrepreneurs, working on Economics.

Linked Research Papers & Trials

Pro & Business members will be able to see all linked papers and trials directly on this topic page.

This information is still available for you by selecting Economics on the Papers and Trials pages respectively.

See the information directly on this page with a paid membership.